Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Central Michigan University Expands College of Medicine
Central Michigan University broke ground in February of 2010 on a $24 million addition to the Health Professions Building in Mount Pleasant. Construction will begin on the 60,000-sf facility in May of 2010 with completion slated for January of 2012.
Momentive Performance Materials Plans Technology Center and Headquarters
Momentive Performance Materials will begin construction in late 2010 on a $75 million technology center in North Greenbush, N.Y. The facility will be located in the Rensselaer Technology Park and is slated for completion in fall of 2012. Upon occupancy of the technology center, Momentive will begin building its $16 million global headquarters at the site. The two buildings will house a total of 250 employees. Momentive is a manufacturer of silicone sealants and adhesives.
REpower Completes Gaspé Wind Farm
REpower has completed construction of a test wind farm in Gaspé, Quebec. Created in partnership with Renewable Energy Systems Canada, the Site Nordique Experimental en EolienCORUS (SNEEC) features two 2.05 megawatt cold climate turbines specially designed for the Canadian 60-hertz network. The wind farm will support research, development, and testing of turbines that can function in extreme temperature conditions. The developer and owner of the project is the Wind Energy TechnoCentre.
Kansas State University Receives Zoonotic Disease Research Funding
Kansas State University was awarded $12 million in February of 2010 by the U.S. Department of Homeland Security to support research in zoonotic and animal disease defense. The grant will establish a Center of Excellence to develop vaccines, diagnostic methods, pandemic modeling tools, and educational programs.
Sinovac Creates Beijing Vaccine Manufacturing Campus
Sinovac Biotech is establishing a five-building vaccine manufacturing campus in Beijing, China. The 32,323-sm project represents an investment of $17.6 million. Housing two production lines, filling and packaging, warehouse space, and a vivarium, the campus will produce vaccines for influenza and enterovirus 71. The facilities will be fully operational in 2012.